Medicare Enrolled

Dr. Nilesh Lodhia, MD

Gastroenterology · Charlotte, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1025 MOREHEAD MEDICAL DR, Charlotte, NC 28204
7043554593
In practice since 2008 (17 years)
NPI: 1922264654 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lodhia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lodhia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lodhia

Dr. Nilesh Lodhia is a gastroenterology specialist in Charlotte, NC, with 17 years of NPI registration. Based on federal Medicare data, Dr. Lodhia performed 154 Medicare services across 129 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lodhia received a total of $692,772 from 27 pharmaceutical and/or device companies across 1194 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lodhia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ 154 Medicare services $692,772 industry payments

Medicare Practice Summary

Medicare Utilization ↗
154
Medicare services
Bottom 12% in NC for gastroenterology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
129
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~9 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
66 $95 $172
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
50 $186 $2,160
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
19 $75 $1,500
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
19 $49 $1,722
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$692,772
Total received (2018-2024)
Avg $98,967/year across 7 years
Top 1% in NC for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
1,194
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$679,699 (98.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,262 (1.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,810 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$105,917
2023
$126,524
2022
$143,401
2021
$90,946
2020
$37,758
2019
$75,881
2018
$112,344

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$47,272
ABBVIE INC.
$27,379
PFIZER INC.
$24,544
E.R. Squibb & Sons, L.L.C.
$5,089
Celgene Corporation
$741
Janssen Scientific Affairs, LLC
$149
Lilly USA, LLC
$130
Takeda Pharmaceuticals U.S.A., Inc.
$126
Celltrion USA Inc.
$117
GENZYME CORPORATION
$116
Phathom Pharmaceuticals, Inc.
$116
Regeneron Healthcare Solutions, Inc.
$82
Ferring Pharmaceuticals Inc.
$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
Top 3 companies account for 93.7% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$146,163
ABBVIE INC.
$127,781
AbbVie, Inc.
$107,800
Janssen Biotech, Inc.
$91,281
Janssen Scientific Affairs, LLC
$87,010
PFIZER INC.
$67,314
AbbVie Inc.
$44,907
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$9,958
Fresenius Kabi USA, LLC
$3,985
Celgene Corporation
$3,485
Takeda Pharmaceuticals U.S.A., Inc.
$908
Ferring Pharmaceuticals Inc.
$527
Regeneron Healthcare Solutions, Inc.
$280
Synergy Pharmaceuticals Inc
$233
Aries Pharmaceuticals, Inc.
$200
Lilly USA, LLC
$195
Covidien LP
$122
Celltrion USA Inc.
$117
GENZYME CORPORATION
$116
Phathom Pharmaceuticals, Inc.
$116
UCB, Inc.
$56
Dynavax Technologies Corporation
$55
Sandoz Inc.
$44
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
HOSPIRA, INC.
$30
Daiichi Sankyo Inc.
$24
Evoke Pharma, Inc.
$24
Top 3 companies account for 55.1% of all-time payments
Associated products mentioned in payments ›
APRISO · CIMZIA · CREON · Cimzia · DUPIXENT · ELEVIEW · ENTYVIO · Entyvio · GIMOTI · HUMIRA · HYRIMOZ · Heplisav-B · Humira · IDACIO · INFLECTRA · INJECTAFER · LINZESS · Motegrity · OMVOH · PillCam · REBYOTA · REMICADE · RINVOQ · SIMPONI ARIA · SKYRIZI · STELARA · TREMFYA · TRULANCE · Trulance · VEGZELMA · VELSIPITY · VOQUEZNA · XELJANZ · XIFAXAN · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for gastroenterology in NC.

Looking for a gastroenterology specialist in Charlotte?
Compare gastroenterologists in the Charlotte area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
83
Per 100K population
7.3
County median income
$83,765
Nearest hospital
CAROLINAS MEDICAL CENTER/BEHAV HEALTH
1.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lodhia is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of NC peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lodhia experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Lodhia performed 66 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lodhia receive payments from pharmaceutical companies?
Yes. Dr. Lodhia received a total of $692,772 from 27 companies across 1,194 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lodhia's costs compare to other gastroenterologists in Charlotte?
Dr. Lodhia's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lodhia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →